Search


	Podcast:		OncLive® On Air
	Episode:		25: Jabbour on Tailoring Treatment With TKIs in CML and Ph+ ALL
	Category:		Science & Medicine
	Duration:		00:15:34
	Publish Date:		2021-07-19 20:24:00
	Description:		Dr. Jabbour discusses the optimal use of ponatinib in chronic myeloid leukemia and data from the 2021 ASCO Annual Meeting with the combination of blinatumomab and ponatinib in Ph-positive acute lymphoblastic leukemia.
	Total Play:		0